Compare Raharja Energi Cepu Tbk. (RATU) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Raharja Energi Cepu Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Raharja Energi Cepu Tbk. trades at Rp4,580 (market cap 12.49T, 11.44M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Raharja Energi Cepu Tbk. is far larger — about 119.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| RATU | SCPI | |
|---|---|---|
Market Cap | 12.49T | 104.4B |
Volume | 11.44M | — |
Lot | 114.36K | — |
Turnover | 53.23B | — |
Average Price | 4,654.9 | — |
Value | 53.23B | — |
Indicative Equilibrium Price | 4,580 | — |
Indicative Equilibrium Volume | 2.62K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Raharja Energi Cepu Tbk.
PT Raharja Energi Cepu Tbk (the Company) was established under the name of PT Syabas Usaha Migas on October 16, 2006 based on notarial deed No. 07 of Indah Setyaningsih, S.H. The Company incorporated in the business group of PT Rukun Raharja Tbk. The Company's ultimate parent entity is PT Rukun Raharja Tbk.
Read more on RATU →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
